Profiel
Dr. Steven D.
Reich, MD, is a Chief Medical Officer at Artelo Biosciences, Inc. and a Vice President-Clinical Development at Actuate Therapeutics, Inc. Dr. Reich was previously employed as a Chief Executive & Medical Officer by Anaborex, Inc. He received his graduate degree from the University of Medicine & Dentistry of New Jersey and a doctorate degree from the University of Medicine & Dentistry of New Jersey.
Actieve functies van Steven D. Reich
| Bedrijven | Functie | Begin |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2018 |
| ACTUATE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Steven D. Reich
| Bedrijven | Functie | Einde |
|---|---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | President | 31-12-2012 |
Opleiding van Steven D. Reich
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | Health Services |
Artelo Biosciences, Inc.
Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
















